Agenus Inc (NASDAQ: AGEN) Could Soar To Much Higher Prices In Coming Months

In the last trading session, 2.1 million Agenus Inc (NASDAQ:AGEN) shares changed hands as the company’s beta touched 1.28. With the company’s per share price at $3.11 changed hands at -$0.79 or -20.38% during last session, the market valuation stood at $66.98M. AGEN’s last price was a discount, traded about -533.12% off its 52-week high of $19.69. The share price had its 52-week low at $3.75, which suggests the last value was -20.58% down since then. When we look at Agenus Inc’s average trading volume, we note the 10-day average is 0.61 million shares, with the 3-month average coming to 393.35K.

Analysts gave the Agenus Inc (AGEN) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.60. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended AGEN as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Agenus Inc (NASDAQ:AGEN) trade information

Instantly AGEN was in red as seen at the end of in last trading. With action -25.18%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -81.25%, with the 5-day performance at -25.18% in the red. However, in the 30-day time frame, Agenus Inc (NASDAQ:AGEN) is -34.36% down. Looking at the short shares, we see there were 3.13 million shares sold at short interest cover period of 7.7 days.

The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 61.13% from its current market value. According to analyst projections, AGEN’s forecast low is 7 with 9 as the target high. To hit the forecast high, the stock’s price needs a -189.39% plunge from its current level, while the stock would need to soar -125.08% for it to hit the projected low.

Agenus Inc (AGEN) estimates and forecasts

Data shows that the Agenus Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -70.98% over the past 6 months, a 25.65% in annual growth rate that is considerably higher than the industry average of 17.10%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 13.79%. The 2024 estimates are for Agenus Inc earnings to increase by 19.74%.

AGEN Dividends

Agenus Inc is expected to release its next quarterly earnings report in December.

Agenus Inc (NASDAQ:AGEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.33% of Agenus Inc shares while 41.73% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 42.29%. There are 41.73% institutions holding the Agenus Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 10.5791% of the shares, roughly 2.15 million AGEN shares worth $36.09 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.6005% or 1.55 million shares worth $25.93 million as of 2024-06-30.